Skyline Dx is dedicated to transforming healthcare through innovative molecular diagnostic tests that address unmet medical needs. Their focus is on developing gene signature-based diagnostics that empower healthcare providers and patients in making informed treatment decisions. By collaborating with esteemed medical centers in the U.S. and Europe, Skyline Dx bridges the gap between biomarker discovery and commercial diagnostic assays, ensuring that their tests are clinically relevant and scientifically robust. With over a decade of experience, they are committed to value-based healthcare and improving patient outcomes through personalized medicine.
Something looks off?